mainly diarrhoea, nausea and vomiting ( As mentioned above, GLP-1RA/SGLT-2i combination therapy may be a better choice for T2DM patients who has poor adequate glycaemic control with monotherapy, and those who wish to lose weight or control SBP
(2024), who observed that Tirzepatide 15 mg had a more significant impact on weight reduction compared to subcutaneous Semaglutide
Maintaining cellular health : Enough NAD+ is vital for energy metabolism and cellular health
70 For example, compound 2j, a triazole-containing derivative, has demonstrated high potency and comparable efficacy to danuglipron in preclinical studies, suggesting it could serve as a lead compound for further development
And guess what glutathione is trying to reduce
Although GLP-1 RAs play a significant role in managing weight in individuals with T2DM, approval for obesity treatment has only been granted to liraglutide (3.0 mg) by the FDA and EMA and semaglutide (2.4 mg) s.c